Medicine News and Research

RSS

Researchers track human stem cells transplanted into rat brain

Researchers at the Stanford University School of Medicine have illuminated the path taken by human neural stem cells that were transplanted into the brains of rats and mice, and found that the cells successfully navigate toward areas damaged by stroke.

5 Jun 2007

Blocking stress protein decreases Alzheimer's peptide

Scientists revealed in November 2006 that stress increases production in mice of a brain peptide critical to Alzheimer's disease.

5 Jun 2007

African-American men understimate risk of prostate cancer

Many African-American men radically underestimate the likelihood that having a needle biopsy for suspected prostate cancer will result in a cancer diagnosis, according to a study from the University of Chicago Medical Center.

5 Jun 2007

breakthrough in the treatment of idiopathic pulmonary haemosiderosis

Researchers at Queen Mary University London and the University of Leicester and have announced a potential breakthrough in the treatment of a rare but devastating medical condition that can affect children and young people.

5 Jun 2007

Time-of-flight positron emission tomography provides benefits for cancer patients

Moving from computer simulation to patient images, researchers are now demonstrating the benefits that time-of-flight (TOF)/PET (positron emission tomography) imaging can provide for cancer patients.

5 Jun 2007

What causes Alzheimer's disease?

Researchers tied the accumulation of the toxic brain protein beta-amyloid to Alzheimer's disease, according to a study reported at the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals.

5 Jun 2007

How and why weight-reducing surgery sometimes cures diabetes

95% of morbidly obese people – those with a Body Mass Index of over 40 – have Type 2 diabetes, sometimes known as maturity-onset diabetes.

5 Jun 2007

Study finds lymphoma drug effective over long term

Eight years after being treated with a new drug for non-Hodgkin's lymphoma, 86 percent of patients were still alive and half had not had a relapse of their disease, according to researchers from the University of Michigan Comprehensive Cancer Center.

5 Jun 2007

Circulating tumor cells predict how prostate cancer patients do with chemotherapy

The number of tumor cells circulating in the bloodstream of patients with metastatic, hormone-resistant, prostate cancer can predict how they will do with chemotherapy, according to results of an international trial.

5 Jun 2007

TB test offers patients quicker and easier diagnosis

A new test for diagnosing TB offers a quick and simple alternative to existing three-day methods, according to research published in the journal Clinical Infectious Diseases.

5 Jun 2007

Chromium picolinate and biotin combo improves blood sugar control in people with type 2 diabetes

Nutrition 21, Inc. (NASDAQ: NXXI) today announced new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).

5 Jun 2007

Link between khat use and mental illness

Researchers investigating the evidence for a potential causal link between khat use and mental illness - in the first ever systematic review of the topic - have called for improved research on the stimulant plant, and its possible association with psychiatric disorders.

5 Jun 2007

Exposure to pesticides and traumatic head injury are associated with Parkinson's disease

The work, which is published in the journal Occupational and Environmental Medicine, was carried out under the Fifth Framework Programme (FP5) Geoparkinson project, which aimed to investigate how genetic and environmental factors interact to cause Parkinson's disease and related conditions.

5 Jun 2007

Protein S-100 linked to melanoma recurrence

Higher levels of a protein called S-100 in patients with melanoma may correlate with a higher risk of having the disease return, say researchers at the University of Pittsburgh Cancer Institute (UPCI), who presented their findings today at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

5 Jun 2007

78 percent of living right liver donors experienced post-operative complications

More than 78 percent of living right liver donors experienced post-operative complications, according to a new study that uses a replicable complication classification system. Most of the complications were minor, though some were more serious.

5 Jun 2007

PET plus CT - best test for ovarian cancer

An advanced molecular imaging technique influenced the management of women with ovarian cancer, detected more sites of disease and identified women whose disease was likely to progress, according to an Australian study released during the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals.

5 Jun 2007

PET/CT best for monitoring Crohn's disease

The molecular imaging power of PET/CT is invaluable in noninvasively monitoring Crohn's disease,a chronic inflammatory disease of the gastrointestinal tract that mainly affects young people, according to a study released by Belgian scientists at the 54th Annual Meeting of SNM.

5 Jun 2007

PET accurately identifies esophageal cancer patients' positive responses to chemotherapy

Early metabolic imaging with positron emission tomography (PET) accurately identifies patients responding to chemotherapy for esophageal cancer, noted German researchers at the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals.

5 Jun 2007

Key source of chronic pain appears to be an old memory trace stuck in the prefrontal cortex

Why do so many people continue to suffer from life-altering, chronic pain long after their injuries have actually healed"

5 Jun 2007

Findings from study of immunotherapy vaccine in prostate cancer patients

Data from an ongoing study designed to explore the biologic and clinical activity of cancer immunotherapy sipuleucel-T, or Provenge, in patients with early stage recurrent prostate cancer who have a rising serum prostate specific antigen (PSA) level, but who have not yet developed metastatic disease will be presented by Oregon Health & Science University Cancer Institute researchers.

5 Jun 2007